Background: Age-related sarcopenia describes loss of muscle strength and often
Introduction
Age-related sarcopenia is a syndrome characterized by a progressive loss of skeletal muscle mass and quality (or strength) resulting in impaired physical performance (1, 2) . Age-related loss of muscle mass is often accompanied by gain in adipose tissue, thus sarcopenic obesity describes a clinical entity in which these two states are thought to act together to increase risk more than the additive effect of the two factors alone in the pathophysiology of both metabolic, functional impairments, and mortality risk (3) (4) (5) (6) (7) (8) (9) .
There is limited evidence on the association between sarcopenic obesity and mortality, although data from several cohort studies suggest that sarcopenic obesity does not confer any greater risk than sarcopenia alone (8, 9) . In constrast, other cohort data have shown that the combination of obesity and high hand grip strength is associated with lower risk of mortality in older adults (10) . Nevertheless, when obesity was defined from waist circumference and high triglycerides, the combination of abdominal obesity and sarcopenia was associated with the highest risk of mortality (11) . These studies, however, relied on a single baseline clinical visit to assess sarcopenia and body composition, and did not examine changes over time. Indeed, changes in sarcopenia status can be best captured using repeat longitudinal clinical assessments. The aim of our study was therefore to first examine the association of sarcopenia and obesity at baseline with mortality over 8 years follow up; second we examined associations between changes in muscle strength and weight on risk of mortality. Analyses were performed on a well characterised community sample of older adults. In our study we defined "sarcopenia" using the lowest sex specific tertile of hand grip strength.
Methods

Study sample and procedures
The English Longitudinal Study of Ageing (ELSA) is an ongoing cohort study of a nationally representative sample of the English population born on or before 29 February 1952 living in private households (12) . A multi-stage stratified probability sampling method was used to recruit the sample. Participants gave full, informed written consent to take part in the study For the key exposure measure, grip strength, there were no upper age limits although respondents were excluded if they had swelling or inflammation, severe pain, or a recent injury or surgery to the hand in the preceding 6 months.
Handgrip and body mass index
Handgrip strength (kg) of the dominant hand was assessed using the Smedley hand-held dynamometer (Stoelting Co, IL, USA ), using the average of three measurements.
Participants were required to hold the device at a right angle to their body and exert maximum force for a couple of seconds when instructed. Successive trials were alternated between dominant and non-dominant hands. Nurses measured participants' body weight without shoes and in light clothing to the nearest 0.1 kg using Tanita electronic scales (Tanita Co, IL, USA), and height was measured using a stadiometer with the Frankfurt plane in the horizontal position; body mass index (BMI) was calculated using the standard formula [weight (kg)/height 2 (m 2 )].
Covariates
At baseline, trained interviewers collected information on self -reported cigarette smoking (current, previous or non-smoker), the self -reported frequency of participation in physical activities (more than once per week, once per week, one to three times per month, hardly ever), self -reported physician-diagnosed cardiovascular diseases, longstanding illness, depressive symptoms (assessed using the self-reported 8-item Centre of Epidemiological Studies Depression (CES-D) scale (13) . Based on previous work in ELSA showing robust doseresponse associations with mortality (14) , physical activity was further categorised into three groups classified as: inactive (no moderate or vigorous at least once a week); moderate activity at least once a week (but no vigorous), and vigorous activity at least once a week. Depressive symptoms were categorised as a binary variable (CES-D score 0 -3 [ref] ; or > 3). Self-reported wealth was used as our measure of socioeconomic status. The wealth variable comprised the total value of the participant's home (excluding mortgage), financial assets such as savings, business assets, and physical wealth such as artwork or jewellery, which has been shown to best capture the material resources available to older adults (15) .
Wealth was grouped into quintiles relative to the ELSA sample.
Statistical analysis
We created sex specific tertiles of grip strength; the range of handgrip strength at baseline in men was 4 - Sarcopenic obesity was defined as obese individuals (BMI ≥ 30 kg/m 2 ) in the lowest tertile of sex specific grip strength (<35.3 kg men; < 19.6kg women). Non-obese were defined as BMI 18.5 -29.99 kg/m 2 and underweight participants were excluded to prevent possible reverse causation (as underweight is often a marker of serious illness) (16) . We used Cox proportional hazards regression models to examine associations between sarcopenic obesity and death. Age at death was recorded and years were the time scale for the followup. For consenting participants with no record of an event, the data were censored at February 2012. The proportional hazards assumption was examined by using plots of the Nelson-Aalen cumulative hazard estimates. In preliminary analyses, there was no evidence of effect modification according to sex, thus data for men and women were pooled and sexadjusted. We estimated models that were initially adjusted for age and sex. The final models were additionally adjusted for physical activity, smoking, depressive symptoms, long standing illness, and wealth. These covariates were selected a priori based on previous literature (8,9). The analyses described above were repeated using Foundation for the National Institutes of Health Biomarkers Consortium (FNIH) sex-specific handgrip strength cutoffs (men <26 kg; women <16kg) to define sarcopenia (1). We performed sensitivity analyses excluding participants who died in the first two years of follow up and those with doctor diagnosed cardiovascular diseases at baseline. In the final set of analyses we examined the association between changes in hand grip strength and weight on risk of mortality. Weight change was defined as an increase or reduction in 5% of initial body mass (17) , and loss of grip strength was defined as reduction in 5% of initial hand grip between clinical assessment waves 2 to 4. All analyses were conducted using SPSS (version 22).
Results
A total of 8,688 participants (82% of wave 1 participants) attended the wave 2 (baseline) clinical assessment. The analytic sample comprised 6,864 men and women (aged 66.2 ± (SD) 9.5 years, 45.6% men) (see Figure 1) The baseline characteristics are displayed in Table 1 . Participants in the highest tertile of grip strength (non-obese and obese) were younger than participants with medium and low grip strength. Non-obese participants with high grip strength were more physically active, wealthier, displayed lower levels of depressive symptoms and reported less disease than other participants.
During an average follow up of 7.6 years (median, 8.1; range 0 -8.1 yrs) there were 906 deaths. We observed a "U"-shaped association between BMI and mortality, with the overweight category demonstrating lowest risk of mortality (see Supplemental Model 2) . In additional analyses we categorised participants using FNIH sex-specific handgrip strength cut-offs (men <26 kg; women <16kg) to identify sarcopenia, and 12.7% of the sample met the threshold. Compared with the reference group (non-obese and non-sarcopenic), the increased risk of all-cause mortality was similar in sarcopenic (age/sex adjusted HR, 1.22; 1.02, 1.45) and in sarcopenic obese (1.22; 0.93, 1.61), although associations did not persist after adjustment for all covariates (physical activity, smoking, depressive symptoms, long standing illness, and wealth) (Supplemental Table 2 ). Results were similar in sensitivity analyses excluding participants who died in first two years of follow up and those with doctor diagnosed cardiovascular diseases at baseline (Supplemental Table 3 ).
Around 11.5% of the sample gained weight and 12.0% lost weight over 4 years follow-up, and 52.8% experienced at least a 5% reduction in handgrip strength. Table 3 demonstrates that all-cause mortality risk was significantly greater in participants experiencing weight loss over 4 years (2.21; 1.32, 3.71) and reduced hand grip strength (1.53;1.07, 2.17), with the highest risk in those with weight loss and strength reduction (3.77; 2.54, 5.60). No excess risk was observed in either of the weight gain groups. Three measures were used to investigate biological interaction between weight loss and sarcopenia in relation to mortality (18) : the relative excess risk due to interaction (RERI); the attributable portion due to interaction (AP); and the synergy index (S) (RERI and AP would be equal to 0 and S would be equal to 1 if there were no biological interaction). The interaction was modelled as 2 × 2 categories, comprising a binary weight loss variable (yes or no) and binary grip strength loss variable (yes or no). Although there appeared to be some evidence of biological interaction, (RERI=0.23, 95% CI: -1.56, 2.02; AP= 0.07, 95% CI: -0.46, 0.60; S=1.11, 95% CI: 0.48, 2.55) the effect estimates were not statistically significant.
Discussion
The main aim of this study was to examine associations between sarcopenic obesity and mortality. A novel addition to the area was to examine the association between changes in muscle strength and weight on risk of mortality. Our main findings showed sarcopenic obesity did not confer any greater risk than sarcopenia alone. In fact, body mass index was a poor predictor of mortality. In contrast, using data from repeat clinical assessments, we showed that weight loss in combination with loss of muscle strength presented the greatest risk. Loss of lean muscle mass and gain in adiposity is considered a hallmark of ageing. That weight gain combined with loss of muscle strength was not associated with risk of mortality in the present study challenges commonly held belief in the area.
Previous evidence has suggested that overweight and obesity are not as adverse in elderly populations (10, 19) , and that muscle mass may be more strongly associated with mortality than obesity (8, 20) . However, results may be biased when using BMI assessed from a single time point as morbidity is a positive function of the duration of obesity, and effects may be obscured when obese participants fall into normal weight categories due to rapid weight loss from underlying disease (21) . In the present study obesity itself was not associated with mortality when compared to a normal weight reference category alone, although the results changed when the reference category was refined to include non-obese with grip strength in the highest tertile.
Low grip strength may be explained by factors other than low muscle mass, such as underlying disease and general health status (22) . Indeed, many individuals with weakness may not have low muscle mass. This had led to suggestions of a distinct term, dynapenia (23) . Nevertheless, associations between grip strength and mortality have been consistently observed in cohort studies (24) , including some with follow-up of over 20 years in which the prevalence of sub-clinical disease and existing comorbidities at baseline was low. Data on skeletal muscle mass were not available in the present cohort and we relied on measurements of muscle strength alone. Nevertheless, while lean mass and strength (muscle quality) may not decline at the same rate, loss of lean mass is strongly associated with strength decline in both men and women (25) . We used the suggested cut points for weakness according to the FNIH criteria (1). However, only 12.7% of the sample met the threshold for weakness based on their handgrip thus limiting our statistical power. Recent evidence has suggested aerobic fitness may have additive and multiplicative interactions with muscle strength in relation to all-cause mortality (26) , although such data were not available in the present study.
ELSA is a nationally representative cohort, although the present sample included younger and healthier participants than the overall cohort due to loss of older, more disadvantaged men and women. Thus the present findings might reflect a conservative estimate of the true effects. The covariates were self-reported, and imprecise measurement may have led to residual confounding.
In conclusion, sarcopenic obesity did not confer any greater mortality risk than sarcopenia alone in a sample of community dwelling older adults. Weight loss in combination with a reduction in muscle strength presented the greatest risk.
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